VRNA

Verona Pharma

125 hedge funds and large institutions have $957M invested in Verona Pharma in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 14 closing their positions.

Holders
125
Holders Change
+12
Holders Change %
+10.62%
% of All Funds
1.82%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
27
Increased
43
Reduced
33
Closed
14
Calls
$10.8M
Puts
$10.5M
Net Calls
+$311K
Net Calls Change
+$608K
Name Holding Trade Value Shares
Change
Shares
Change %
FTM
126
First Turn Management
California
-$15.7M -973,130 Closed
ABG
127
Ally Bridge Group
New York
-$11.9M -736,738 Closed
Axa
128
Axa
France
-$4.47M -277,784 Closed
SCM
129
Superstring Capital Management
New York
-$4.17M -259,383 Closed
PAMP
130
Polar Asset Management Partners
Ontario, Canada
-$1.55M -96,500 Closed
UOC
131
UBS O'Connor
Illinois
-$584K -36,305 Closed
Bank of New York Mellon
132
Bank of New York Mellon
New York
-$477K -29,676 Closed
Capstone Investment Advisors
133
Capstone Investment Advisors
New York
-$412K -25,616 Closed
VF
134
Virtu Financial
New York
-$373K -23,180 Closed
CSS
135
Cubist Systematic Strategies
Connecticut
-$220K -13,682 Closed
QT
136
Quantbot Technologies
New York
-$39.5K -2,458 Closed
EC
137
EntryPoint Capital
New York
-$18.9K -1,175 Closed
CA
138
CoreCap Advisors
Michigan
-$10.6K -657 Closed
Zurich Cantonal Bank
139
Zurich Cantonal Bank
Switzerland
-$32 -2 Closed